These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 2828992)

  • 1. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
    Dong XW; Parsons CG; Headley PM
    Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.
    Parsons CG; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):523-32. PubMed ID: 2555011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of mu-, delta- and kappa-opiate receptor agonists on the bioelectrical activity of the viscerosomatic convergent neurons in the posterior horn of the spinal cord].
    Kasparov SA
    Eksp Klin Farmakol; 1993; 56(1):13-6. PubMed ID: 8391888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
    Piercey MF; Einspahr FJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):267-71. PubMed ID: 2552077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the selectivity of intravenous mu- and kappa-opioids between nociceptive and non-nociceptive reflexes in the spinalized rat.
    Parsons CG; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):544-51. PubMed ID: 2555013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulus intensity and the comparative efficacy of mu- and kappa-opioid agonists on nociceptive spinal reflexes in the rat.
    Thorn SA; Herrero JF; Headley PM
    Brain Res; 1994 Nov; 663(2):352-6. PubMed ID: 7874523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroadaptation of rats to kappa agonists U-50,488 and tifluadom.
    Murray C; Cowan A
    NIDA Res Monogr; 1988; 81():136-42. PubMed ID: 2841602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the rat.
    Herrero JF; Headley PM
    Br J Pharmacol; 1993 Sep; 110(1):303-9. PubMed ID: 8220893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord.
    Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F
    Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.